Integrin β5 Antibody

About the Target

ITGB5 is a target of interest in many antibody-based workflows. The αv-β-family of integrins plays a pivotal role in tumorigenesis, therapy response, and cancer stem cell biology. Integrin β5, a member of this family, is essential in breast carcinomas, as evidenced by studies using RNA interference to deplete it and subsequent re-expression. Depletion of integrin β5 in triple-negative breast carcinoma cells significantly reduces tumor take, growth, and angiogenesis, with a concomitant decrease in VEGF-A expression. Depending on the literature source, ITGB5 may also be discussed as Integrin beta5.

Reported cellular context includes cell membrane and membrane, which can matter when signal is compared across treatments or changing cell states. Following ITGB5 across matched perturbations can help separate abundance effects from shifts in localization, complex assembly, or pathway state.

Research Context

ITGB5 is commonly interpreted in the context of cancer, angiogenesis, and cell signaling research, and readouts are often stronger when a study separates expression changes from compartment-level redistribution. When reported signal spans cell membrane and membrane, a defined reference condition can make comparisons more interpretable across perturbations, passages, or replicate sets.

Consider these angles when interpreting target-level changes:

• apparent redistribution between cell membrane and membrane across matched conditions
• changes associated with proliferative state, oncogenic signaling, or treatment response
• differences related to endothelial activation, vessel remodeling, or growth-factor exposure
• signal-dependent shifts after ligand, inhibitor, or growth-factor perturbation

Variant Considerations

If your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior for ITGB5. This can help when protocols evolve over time and the goal is to compare experiments using a stable reference workflow.

Standardize sampling time, control choice, and downstream analysis thresholds so apparent differences in ITGB5 reflect biology rather than handling. When interpreting ITGB5, it is often useful to decide early whether the main question is overall abundance, compartmental enrichment, or context-dependent redistribution.

For multi-run studies, a shared reference condition can keep ITGB5 trends easier to compare across datasets. That kind of consistency is especially helpful when follow-up work expands to new perturbations, model systems, or longitudinal collections.